Patients with follicular lymphoma experiencing early progression or death within twenty four months after immunochemotherapy face poor outcomes.
Researchers say barriers such as time constraints and financial limitations complicate fertility counseling and preservation for patients with lymphoma.
This month is Veganuary, a good time to try a plant-based diet. A convert, and experts, describe its many health benefits.
Searching for the safest countries to visit? An annual report ranks the safest countries in the world—with Iceland coming out on top. The U.S. didn’t…
Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland Pumpinheart Ltd, Galway, Ireland Tissue Engineering Research Group, RCSI University of Medicine…
Gauthier and colleagues evaluated concomitant ibrutinib and anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in a study of patients with chronic ly
Nephrology Times is proud to feature Freely Filtered and Channel Your Enthusiasm, leading health care podcasts covering the latest research in the nephrology space.
While CAR-T cell therapy has emerged as a transformative salvage option for around 40% of patients, long-term data on allo-HSCT remain sparse, research shows.
The U.S. Surgeon General’s office released a new advisory on the link between alcohol consumption and increased risk for cancer. The advisory reports alcohol use…
And a bit of hope for 2025
Ferring has advanced three clinical trials assessing nadofaragene as a monotherapy and combination therapy for NMIBC.
